Bank of Hawaii’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-455
Closed -$209K 244
2023
Q1
$209K Sell
455
-64
-12% -$30.5K 0.01% 241
2022
Q4
$266K Sell
519
-13
-2% -$6.6K 0.02% 228
2022
Q3
$242K Buy
532
+18
+4% +$8.61K 0.02% 223
2022
Q2
$248K Buy
514
+20
+4% +$9.89K 0.02% 220
2022
Q1
$243K Buy
+494
New +$226K 0.01% 240
2016
Q1
Sell
-4,640
Closed -$647K 340
2015
Q4
$647K Sell
4,640
-185
-4% -$25.5K 0.07% 210
2015
Q3
$676K Sell
4,825
-1,765
-27% -$265K 0.08% 199
2015
Q2
$1.08M Sell
6,590
-930
-12% -$149K 0.11% 161
2015
Q1
$1.16M Sell
7,520
-1,830
-20% -$261K 0.11% 163
2014
Q4
$1.18M Buy
9,350
+3,370
+56% +$416K 0.11% 161
2014
Q3
$715K Sell
5,980
-60
-1% -$6.88K 0.07% 209
2014
Q2
$650K Buy
6,040
+430
+8% +$44.3K 0.06% 231
2014
Q1
$559K Buy
+5,610
New +$507K 0.06% 241

Other funds holding ELV

Bank of Hawaii's ELV Position: Q2 2023 in Review

Bank of Hawaii sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 455 shares — an estimated $209K sold.

Bank of Hawaii first reported a position in ELV in Q1 2014 and held it in 13 quarters. The position peaked at $1.18M in Q4 2014. 1,524 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Bank of Hawaii reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • Bank of Hawaii sold 455 Elevance Health shares in Q2 2023, an estimated $209K.
  • Bank of Hawaii first reported a position in Elevance Health in Q1 2014 and held it in 13 quarters.
  • Bank of Hawaii's Elevance Health position peaked at $1.18M in Q4 2014.
  • 1,524 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Bank of Hawaii's 13F filing for Q2 2023, filed 10 Aug 2023.